#

Pharmaceutical Companies

: 153
Apple has cut its employees budget for AI use / Photo: achinthamb / Shutterstock.com
Review·
Top Stories This Morning: Banks Are Selling $40 Billion in SpaceX Debt; Apple to Cut AI Spending
Novo Nordisks results exceeded expectations / Photo: Kittyfly / Shutterstock.com
News·
Sales of weight-loss pills exceeded forecasts by 20%. Will Novo reclaim the lead from Lilly?
Pfizer Has Found New Sources of Growth Following a Decline in Sales of COVID-19 Drugs / Photo: Tada Images / Shutterstock.com
News·
Pfizer Raises Annual Revenue Forecast: It Has Found New Sources of Growth in the Wake of COVID
Eli Lilly, a pharmaceutical company, reported its third-quarter earnings and revenue. Photo: Tada Images/Shutterstock.com
News·
Eli Lilly's stock hit a new record high. How did the company impress investors?
Photo: Taljat David / Shutterstock
News·
A key Novartis drug failed to meet expectations. The stock price fell
Detailed phase III trial results for the vaccine were set to be presented at the European Society for Medical Oncology conference this weekend / Photo: Tada Images / Shutterstock.com
News·
Moderna plunges 25% as leaked cancer vaccine data falls short of lofty expectations
Life sciences companies stand to gain from a surge in AI fueled drug discovery, says Citrini Research / Photo: Alohaflaminggo / Shutterstock.com
Small Caps·
+1
·
Citrini bets on biotech after using Anthropic AI to design potential drug
Goldman Sachs recommends consumer-facing stocks, saying energy prices and interest rates will fall next year / Photo: pimpampix / Shutterstock
News·
Goldman names 23 'unloved' defensive stocks as tech falters
Data on the subcutaneous form of Skyrizi likely drove the rise in AbbVies stock / Photo: ChrisStock82 / Shutterstock.com
News·
Pharmaceutical companies benefited from the sell-off in the AI sector. Which stocks are nearing their all-time highs?
Liquidia has announced a settlement resolving all litigation with rival United Therapeutics / Photo: Liquidia
Small Caps·
Pulmonary hypertension drugmaker Liquidia soars 27% after settling patent battle
BioNTech shares fell after unsuccessful trials of its mRNA drug / Photo: Kittyfly / Shutterstock
News·
BioNTech reported another setback in the development of cancer drugs. Its stock plummeted
Pacira’s EXPAREL treats acute postsurgical pain / Photo: Unsplash/Roberto Sorin
Small Caps·
Pacira soars 44% as Viatris agrees to buy biotech to boost non-opioid pain portfolio
Load more